Anti‐IL‐4Rα mAb (dupilumab) vs placebo (on top of topical steroids)
Adverse events ‐ nasopharyngitis, including sore throat · patients with severe chronic rhinosinusitis with nasal polyps
Anti‐IL‐4Rα mAb (dupilumab) showed no clear difference in adverse events ‐ nasopharyngitis, including sore throat (longest… compared with placebo (on top of topical steroids) (low certainty).
1 finding from 1 review
- RR 0.95 [0.72, 1.25]3 studies · 783 participantsLow